Opens in a new tab or window Roughly half as many patients with cirrhosis in remission from overt hepatic encephalopathy (OHE) experienced a breakthrough episode with rifaximin monotherapy ...

MONDAY, Oct. 28, 2024 (HealthDay News) -- For patients with a history of overt hepatic encephalopathy (OHE), rifaximin ...

This post hoc analysis of data from two randomized trials evaluated the efficacy of Xifaxan monotherapy compared to lactulose monotherapy for risk reduction of overt hepatic encephalopathy (OHE ...

Get detailed information on Rifaximin, including pronunciation ... certain bacteria and liver disease affecting the brain (hepatic encephalopathy). It prevents the growth of bacteria inside ...

This study shows that the incidence of hepatic encephalopathy was lower in cirrhotic patients with upper gastrointestinal bleed treated with lactulose as compared with patients not treated with ...

The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version ...

Medicare Part D prescription drug coverage helps cover the cost of Xifaxan (rifaximin). Doctors may recommend Xifaxan to treat irritable bowel syndrome with diarrhea (IBS-D) or to help prevent overt ...

Doctors may recommend Xifaxan to treat irritable bowel syndrome with diarrhea (IBS-D) or to help prevent overt hepatic encephalopathy. If a person has Medicare Advantage with prescription drug ...

Companiesannounced the first look at its late-stage RED-C clinical trial program which will be presented at the American ...

Xifaxan (rifaximin) is an oral tablet prescribed to treat some forms of diarrhea and other conditions. Xifaxan may not be safe to take while pregnant. It might be safe to take while breastfeeding ...